We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

115 hedge funds and large institutions have $358M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 28

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

14% more call options, than puts

Call options by funds: $2.8M | Put options by funds: $2.47M

1% more funds holding

Funds holding: 114 → 115 (+1)

34% less capital invested

Capital invested by funds: $541M → $358M (-$184M)

Holders
115
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
41
Reduced
28
Closed
13
Calls
$2.8M
Puts
$2.47M
Net Calls
+$334K
Net Calls Change
-$415K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$26.3M
2
Fisher Asset Management
Fisher Asset Management
Washington
+$13.4M
3
JP Morgan Chase
JP Morgan Chase
New York
+$5.92M
4
Goldman Sachs
Goldman Sachs
New York
+$3.98M
5
Nordea Investment Management
Nordea Investment Management
Sweden
+$3.38M

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$8.82M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.77M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$7.83M
4
Morgan Stanley
Morgan Stanley
New York
-$3.68M
5
N
Nuveen
North Carolina
-$3.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$1.85M -$786K -48,244 -26%
RJA
27
Raymond James & Associates
Florida
$1.81M +$34.1K +2,091 +2%
VOYA Investment Management
28
VOYA Investment Management
Georgia
$1.72M -$156K -9,571 -7%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.68M +$170K +10,424 +9%
Ameriprise
30
Ameriprise
Minnesota
$1.64M +$111K +6,796 +6%
UBS Group
31
UBS Group
Switzerland
$1.62M +$1.72M +105,274 +689%
Wells Fargo
32
Wells Fargo
California
$1.43M +$157K +9,606 +10%
NIM
33
Needham Investment Management
New York
$1.19M +$994K +61,000 +222%
Two Sigma Investments
34
Two Sigma Investments
New York
$1.14M -$8.82M -541,023 -86%
PPA
35
Parametric Portfolio Associates
Washington
$990K +$739K +45,376 +160%
Jane Street
36
Jane Street
New York
$870K +$410K +25,186 +64%
Swiss National Bank
37
Swiss National Bank
Switzerland
$866K – – –
GG
38
Golden Green
South Carolina
$844K +$50.5K +3,098 +5%
JAM
39
Jupiter Asset Management
United Kingdom
$821K +$325K +19,966 +48%
Federated Hermes
40
Federated Hermes
Pennsylvania
$807K +$980K +60,133 New
SG Americas Securities
41
SG Americas Securities
New York
$800K +$313K +19,229 +48%
AA
42
ALPS Advisors
Colorado
$696K -$57.3K -3,518 -6%
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$695K – – –
E
44
Ergoteles
New York
$681K +$827K +50,767 New
CA
45
CHI Advisors
New York
$671K – – –
SFI
46
Susquehanna Fundamental Investments
Pennsylvania
$671K +$815K +50,020 New
EMG
47
ETF Managers Group
New Jersey
$647K +$708K +43,446 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$632K +$17.6K +1,078 +2%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$616K – – –
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$608K -$142K -8,731 -16%
1
2
3 4 5

GTHX Hedge Fund Activity: Q3 2021 in Review

115 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q3 2021, worth a combined $358M — down 34% from $541M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GTHX positions and 13 closed out — a net gain of 2 holders — while 41 added to existing stakes and 28 trimmed.

The largest buyer was State Street, adding an estimated $26.3M. The largest seller was Two Sigma Investments, cutting an estimated $8.82M.

  • 115 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q3 2021, up from 114 in Q2 2021.
  • Funds reported $358M of G1 Therapeutics, Inc. Common Stock stock for Q3 2021, down 34% quarter-over-quarter.
  • 15 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q3 2021 and 13 closed out, a net change of +2 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q3 2021 was State Street, an estimated $26.3M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q3 2021 was Two Sigma Investments, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2021.